Form 8-K - Current report:
SEC Accession No. 0000950170-23-011915
Filing Date
2023-04-05
Accepted
2023-04-05 16:19:35
Documents
13
Period of Report
2023-04-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20230405.htm   iXBRL 8-K 59493
  Complete submission text file 0000950170-23-011915.txt   215644

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srzn-20230405_pre.xml EX-101.PRE 12994
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srzn-20230405_lab.xml EX-101.LAB 17592
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srzn-20230405_def.xml EX-101.DEF 13694
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srzn-20230405.xsd EX-101.SCH 3109
7 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20230405_htm.xml XML 6585
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 23802811
SIC: 2836 Biological Products, (No Diagnostic Substances)